cefaclor

(redirected from Ceclor)
Also found in: Medical.

cef·a·clor

 (sĕf′ə-klôr′)
n.
A broad-spectrum cephalosporin antibiotic, C15H14ClN3O4S, that is given orally.
[cefa- + c(h)lor(ine).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

cefaclor

n cefaclor m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Lilly recently sold the rights in China for two legacy antibiotics, Ceclor andVancocin, as well as a manufacturing facility in Suzhou, to Eddingpharm, a China-based specialty pharmaceutical company, in a transaction valued at $375 million.
TOP 25 COMPANIES AND BIOPHARMA REPORT
United States-based Eli Lilly and Company (NYSE: LLY) has signed a contract to sell the rights in China for two legacy Lilly antibiotic medicines, Ceclor and Vancocin and a manufacturing facility in Suzhou, China that produces Ceclor, to China-based Eddingpharm, it was reported yesterday.
Eli Lilly to sell China rights for two antibiotic medicines and manufacturing facility in Suzhou to Eddingpharm
24 April 2019 - US-based drugmaker Eli Lilly and Company (NYSE: LLY) has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic medicines, Ceclor and Vancocin, as well as a manufacturing facility in Suzhou, China that produces Ceclor, to Eddingpharm, a China-based specialty pharmaceutical company, the company said.
Lilly Sells Legacy Antibiotics Brands and Manufacturing Facility in China
Healthcare company Eli Lilly and Company (NYSE:LLY) reported on Monday the launch of an agreement to sell the Chinese rights of two legacy Lilly antibiotic medicines, Ceclor and Vancocin, as well as the Ceclor manufacturing facility in Suzhou, China, to Eddingpharm, a China-based specialty pharmaceutical company.
Lilly disposes legacy antibiotics brands and manufacturing facility in China
Eli Lilly announced that it has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic medicines, Ceclor and Vancocin, as well as a manufacturing facility in Suzhou, China that produces Ceclor, to Eddingpharm, a China-based specialty pharmaceutical company.
Eli Lilly announces sale of legacy antibiotics brands, facility in China
* Cephalosporins: Cephalexin (Keflex, Keftabs), cefazolin (Ancef), cefaclor (Ceclor), cefuroxime (Ceftin), cefadroxil (Duracef)
Protect yourself against a potentially deadly infection: adults 65 and older have the highest fatality rate from a bacterial infection that attacks the colon
Cephalosporins Examples cefaclor/CECLOR, CECLOR CD cefadroxil/DURICEF cefixime/SUPRAX cefprozil/CEFZIL cephalexin/KEFLEX, KEFTAB
Food + drug interactions
Lilly's Ceclor, launched in the 1970s, became the world's top-selling oral antibiotic, and Humulin, the diabetes drug introduced in 1982, was the world's first human health-care product created using recombinant DNA technology.
50 Great Indiana Businesses: companies making a significant impact on their communities and state through innovation, growth and civic involvement
(11) Over this period, Dura issued several press releases (the "1997 Press Releases") about Spiros and one of its other products, Ceclor. (12) In these announcements, Dura claimed that it would complete satisfactory testing of Spiros and soon receive Food and Drug Administration ("FDA") approval, and would see increasing sales of its respiratory drug Ceclor.
Securities fraud litigation--lost in causation: investors not entitled to presumption of loss causation in fraud-on-the-market cases--Dura Pharmaceuticals, Inc. v. Broudo, 125 S. CT. 1627 (2005)
Dictionary browser ?
Full browser ?